Company intelligence / Profile preview

Chelak iECG

Bellaire, Texas, United States

Ownership: Private
Development stage: Other

Overview

Chelak iECG, in joint venture Kardionav with Catheter Precision, is developing an AI and advanced imaging-driven mapping system to precisely localize ventricular arrhythmias for ablation procedures. Initial clinical research shows enhanced localization accuracy and potential for reducing procedure times. Commercial trials for integrated technology are pending.

Therapeutic areas: Cardiovascular
Modalities: DeviceArtificial intelligence
Industry: Physiological Monitoring

Partnerships

Catheter Precision

Beyond the preview

Go deeper on Chelak iECG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chelak iECG.

Explore the full profile